NY A09535 | 2023-2024 | General Assembly
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on March 20 2024 - 25% progression
Action: 2024-03-20 - referred to health
Pending: Assembly Health Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on March 20 2024 - 25% progression
Action: 2024-03-20 - referred to health
Pending: Assembly Health Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Establishes a generic drug research and development laboratory and production facility to manufacture generic prescription drugs in the state and the empire state biosimilar insulin initiative, which will develop generic forms of the three most widely used forms of insulin.
Title
Establishes a generic drug research and development laboratory and production facility to manufacture generic prescription drugs in the state and the empire state biosimilar insulin initiative, which will develop generic forms of the three most widely used forms of insulin.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2024-03-20 | Assembly | referred to health |